Role of zoledronic acid in treating osteoporosis in post-allogeneic bone marrow transplant patients - A phase II trial.

被引：0
|
作者：
Chamarthy, Usha
Rao, D. Sudhaker
Divine, George
Khan, Shahzad
Janakiraman, Nalini
机构：
[1] Henry Ford Hlth Syst, Bone & Mineral Metab, Hematol Oncol Bone Marrow Transplantat, Detroit, MI USA
[2] Sparrow Reg Canc Ctr, Lansing, MI USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2971.2971
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2971
引用
收藏
页码：842A / 842A
页数：1
相关论文
共 50 条
  • [21] Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial
    Zaher K. Otrock
    Sami T. Azar
    Wael A. Shamseddeen
    Dany Habr
    Adlette Inati
    Suzane Koussa
    Rami A. R. Mahfouz
    Ali T. Taher
    Annals of Hematology, 2006, 85 : 605 - 609
  • [22] PROSPECTIVE MULTICENTER TRIAL OF DONOR BUFFY COAT INFUSION FOR RELAPSED HEMATOLOGIC MALIGNANCY POST-ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    COLLINS, R
    WOLFF, S
    LIST, A
    CHRISTIANSEN, N
    PINEIRO, L
    GREER, J
    GOODMAN, S
    DALTON, W
    GONZALEZ, G
    HERZIG, G
    PHILLIPS, G
    FAY, J
    BLOOD, 1994, 84 (10) : A333 - A333
  • [23] Prophylactic treatment with nilotinib for post-allogeneic stem cell transplantation cytomegalovirus infection: interim analysis of a phase II trial
    Wu, S. J.
    Lin, C. T.
    Lin, W. P.
    Li, C. C.
    Ko, B. S.
    Yao, M.
    Tang, J. L.
    Tien, H. F.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S139 - S139
  • [24] Zoledronic acid in cancer patients with bone metastases: Results of phase I and II trials
    Berenson, JR
    SEMINARS IN ONCOLOGY, 2001, 28 (02) : 25 - 34
  • [25] The Role of Geriatric Assessment in Elderly Patients Submitted to Allogeneic Bone Marrow Transplant: A Retrospective Analysis
    Rodrigues, Morgani
    Koch, Ludmila Muniz
    Rodrigues Souza, Polianna Mara
    Hamerschlak, Nelson
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S347 - S348
  • [26] Zoledronic acid increases bone mineral density in patients with thalassemia intermedia-induced osteoporosis regardless of the incessant bone marrow expansion
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Antoniadou, Lito
    Tsaftaridis, Panagiotis
    Plata, Eleni
    Terpos, Evangelos
    BLOOD, 2007, 110 (11) : 21B - 21B
  • [27] Zoledronic acid increases bone mineral density in patients with thalassemia intermedia-induced osteoporosis despite the continuous bone marrow expansion
    Voskaridou, E.
    Christoulas, D.
    Antoniadou, L.
    Tsaftaridis, P.
    Plata, E.
    Terpos, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 342 - 342
  • [28] RAD001 AND ZOLEDRONIC ACID IN RENAL CELL CARCINOMA PATIENTS WITH BONE METASTASES (RAZOR) - A RANDOMIZED PHASE II TRIAL
    Broom, R. J.
    Hinder, V.
    Sharples, K.
    Proctor, J.
    Duffey, S.
    Pollard, S.
    Fong, P. C. C.
    Forgeson, G.
    Harris, D. L.
    Jameson, M. B.
    O'Donnell, A.
    North, R. T.
    Deva, S.
    Hanning, F. J.
    Grey, A.
    Findlay, M. P. N.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 24 - 24
  • [29] Everolimus and Zoledronic Acid in Patients With Renal Cell Carcinoma With Bone Metastases: A Randomized First-Line Phase II Trial
    Broom, Reuben J.
    Hinder, Victoria
    Sharples, Katrina
    Proctor, Janie
    Duffey, Steven
    Pollard, Stephanie
    Fong, Peter C. C.
    Forgeson, Garry
    Harris, Dean L.
    Jameson, Michael B.
    O'Donnell, Anne
    North, Richard T.
    Deva, Sanjeev
    Hanning, Fritha J.
    Grey, Andrew
    Findlay, Michael P. N.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 50 - 58
  • [30] RAD001 and zoledronic acid in patients with renal cell carcinoma with bone metastases (RAZOR): A randomized phase II trial
    Broom, Reuben James
    Hinder, Vicky
    Sharples, Katrina
    Proctor, Janie
    Duffey, Steven
    Pollard, Stephanie
    Fong, Peter C. C.
    Forgeson, Garry
    O'Donnell, Anne
    Harris, Dean Laurence
    Deva, Sanjeev
    Jameson, Michael B.
    North, Richard T.
    Grey, Andrew
    Findlay, Michael P. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345